Crenshaw Applauds FDA Guidance on Clinical Trials With Psychedelics Following Legislative Push
June 30, 2023
June 30, 2023
WASHINGTON, June 30 -- Rep. Dan Crenshaw, R-Texas, issued the following news release:
Congressman Dan Crenshaw applauds the FDA's decision to issue its first draft guidance on clinical trials for psychedelic drugs in treating mental health conditions like PTSD and TBI - following the introduction of his legislation calling on the FDA to do exactly that.
"I'm glad the FDA is taking this first step of issuing guidance for psychedelic clinical trials -- and listening . . .
Congressman Dan Crenshaw applauds the FDA's decision to issue its first draft guidance on clinical trials for psychedelic drugs in treating mental health conditions like PTSD and TBI - following the introduction of his legislation calling on the FDA to do exactly that.
"I'm glad the FDA is taking this first step of issuing guidance for psychedelic clinical trials -- and listening . . .